Credit Suisse Group AG (CSGN) - Medical Equipment - Advisory Profile

Summary

Credit Suisse Group AG (Credit Suisse) is a global financial services provider. The company provides advisory services, comprehensive solutions and innovative products to institutional clients, companies and high-net-worth private clients, and to retail customers in Switzerland. The company has operations across 50 countries. Credit Suisse offers its products and services through its brands, Credit Suisse and Clariden Leu. The company is headquartered in Zurich, Switzerland.



Credit Suisse aims to grow its client business through increase in market share and strengthening its geographical footprint. In line to its strategy, the group plans to expand its operations across fast growing markets such as Brazil, Southeast Asia, Greater China and Russia, thereby increasing its revenue from 15% in 2010 to 25% by 2014.

GlobalData’s Credit Suisse Group AG (CSGN) - Medical Equipment - Advisory Profile provides an overview of the deals advised by Credit Suisse Group AG in the Medical Equipment market. The report is an essential source of information for Medical Equipment companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Credit Suisse Group AG's deals for the past five years segregated into year, deal type, segment and geography.

Scope

- Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements
- Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information
- Analyzes the advisor’s deals by year, deal type, segment and geography
- Provides detailed information on deal particulars, including information about other advisors involved in the deal
- Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed
- Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period
- Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies)

Reasons to Buy

- Receive detailed information and evaluate the profile of a particular advisor in the market before considering for your business needs
- Peruse all the advisor’s deals in the Industry market
- Access detailed information about the advisor’s financial deals for the past five years that enable you to scrutinize the key deals, which have shaped investment policies
- Identify other potential advisors currently active in your industry, or industry that you wish to foray into
- Compare your advisory services vis-à-vis your competitors’
- Check and identify the advisor that suits your requirements, such as placement agents, book-runners and underwriters
- Examine the breakdown of deals by category and detailed information on major deals incorporated in the advisor’s profile for your academic or business research needs and their suitability to your requirements.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 6
Credit Suisse Group AG, Medical Equipment Deals Advised By Year, 2006 to YTD 2012 7
Credit Suisse Group AG, Medical Equipment Deals Advised By Type, 2006 to YTD 2012 8
Credit Suisse Group AG, Medical Equipment Deals Advised By Region, 2006 to YTD 2012 9
Credit Suisse Group AG, Medical Equipment Deals Advised By Market, 2006 to YTD 2012 10
Credit Suisse Group AG, Medical Equipment Deals Advised Summary, 2006 to YTD 2012 12
Credit Suisse Group AG, Medical Equipment, Deal Details 21
Acquisition 21
Asset Transactions 72
Debt Offerings 80
Equity Offerings 196
Private Equity 225
Recent Developments 239
Corporate Communications 239
Other Significant Developments 239
Appendix 241
Methodology 241
About GlobalData 241
Contact Us 241
Disclaimer 241

List of Tables

Credit Suisse Group AG, Key Facts 1
Credit Suisse Group AG, Medical Equipment Deals Advised Summary, 2006 to YTD 2012 1
Credit Suisse Group AG, Medical Equipment Deals Advised By Year, 2006 to YTD 2012 10
Credit Suisse Group AG, Medical Equipment Deals Advised By Type, 2006 to YTD 2012 11
Credit Suisse Group AG, Medical Equipment Deals Advised By Region, 2006 to YTD 2012 12
Credit Suisse Group AG Deals Advised By Market, 2006 to YTD 2012 13
Credit Suisse Group AG, Medical Equipment Deals Advised Summary, 2006 to YTD 2012 15
Qiagen Completes Acquisition Of Cellestis 24
Novartis Completes Acquisition Of Remaining 23% Stake In Alcon 27
Novartis Completes Acquisition Of Additional 52% Stake In Alcon From Nestle 30
The Blackstone Group Sells 25% Stake In Gerresheimer 33
Technitrol Acquires Sonion 35
Johnson and Johnson Receives European Union Approval To Acquire Synthes For $21 Billion 37
Sanofi-Aventis Completes Acquisition Of Genzyme 40
Glatfelter Completes Acquisition Of Concert Industries From Brookfield Special 43
Reable Therapeutics Acquires DJO 45
Danaher Acquires Sybron Dental Specialties 47
Takeda Pharma Completes Acquisition Of Nycomed International For $13,681 Million 49
Inner Mongolia Free Han and Mongolia Pharma Completes Acquisition Of Echosens For $26.8 Million 52
Novartis Completes Sale Of Novartis Medical Nutrition To Nestle 53
Intel Acquires Wind River Systems 55
Quest Diagnostics Completes Acquisition Of Celera 56
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 59
Air Products and Chemicals Extends Tender Offer To Acquire Airgas 61
Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 64
Bracco Diagnostics Acquires E-Z-EM 66
Honeywell International Completes Acquisition Of Norcross Safety Products From Odyssey Investment Partners 68
Galderma Acquires Q-Med 70
Novartis Acquires 25% Stake In Alcon From Nestle 72
China Medical Technologies Acquires Fluorescent In Situ Hybridization Business From Supreme Well Investments And Molecular Diagnostics Technologies 75
Onex Healthcare Acquires Kodak Health Group Business From Eastman Kodak 77
Siemens Medical Solutions Acquires Diagnostics Division Of Bayer Healthcare 79
Genzyme Completes Sale Of Its Diagnostic Business To Sekisui Chemical 81
Accellent Completes Private Placement Of Senior Notes Due 2017 For $400 Million 83
DuPont Issues $500 Million 5.75% Notes Due 2019 84
Baxter International Completes Public Offering Of 5.375% Senior Notes For $500 Million 86
Royal Philips Electronics Completes Public Offering Of Floating Rate Senior Notes For $350 Million 87
Bayer Completes Public Offering Of Fixed Rate Bonds For $267 Million 89
DuPont Completes Public Offering Of 1.95% Senior Notes Due 2016 For $500 Million 91
Zimmer Holdings Completes Public Offering Of 1.4% Senior Notes Due 2014 For $250 Million 93
DuPont Issues $400 Million 4.75% Notes Due 2015 95
DuPont Completes Senior Notes Offering Of $1,000 Million 97
Novartis Completes Private Placement Of 3.5% Bond For $686 Million 98
Royal Philips Electronics Completes Public Offering Of 6.875% Senior Notes For $1,000 Million 99
Agilent Technologies Completes Public Offering Of 6.5% Senior Notes For $600 Million 101
Bayer Completes Public Offering Of Floating Rate Bonds For $401 Million 103
Eli Lilly Completes Public Offering Of 5.2% Notes For $1,000 Million 105
Dupont Completes 5.25% Notes Offering For $600 Million 107
Novartis Completes Public Offering Of 4.125% Bonds For $2,000 Million 108
China Medical Technologies Completes Public Offering Of Convertible Senior Notes For $276 Million 110
Diagnosticos da America Completes Private Placement Of 8.75% Notes For $250 Million 111
Ecolab Completes Public Offering Of Senior Unsecured Notes For $250 Million 112
Bayer Completes Public Offering Of Floating Rate Bonds For $244.45 Million 114
Eli Lilly Completes Public Offering Of 5.55% Notes For $795 Million 115
DuPont Completes 5.6% Notes Offering For $400 Million 117
Pregis Completes Private Placement Of Senior Secured Floating Rate Notes For $184 Million 118
Bio-Rad Labs Completes Private Placement Of 8% Senior Subordinated Notes For $300 Million 119
Novartis Completes Public Offering Of 5.125% Bonds For $3,000 Million 120
Dupont Completes 6% Notes Offering For $1.25 Billion 122
Agilent Technologies Completes Public Offering Of 2.5% Senior Notes For $250 Million 124
Novartis Completes Public Offering Of 1.9% Senior Notes For $2,000 Million 126
Bayer Completes Public Offering Of 3.575% Bonds For $170 Million 128
Novartis Completes Private Placement Of 3.625% Bond For $784 Million 130
Royal Philips Electronics Completes Public Offering Of 5.75% Senior Notes For $1,250 Million 131
Zimmer Holdings Completes Public Offering Of 3.375% Senior Notes Due 2021 For $300 Million 133
DuPont Completes Public Offering Of 4.25% Notes Due 2021 For $500 Million 135
DuPont Completes Public Offering Of 3.625% Senior Notes Due 2021 For $1,000 Million 137
Genzyme Completes Private Placement Of 3.6% Notes For $500 Million 139
Baxter International Completes Public Offering Of 1.8% Senior Unsecured Notes For $300 Million 140
DuPont Completes Public Offering Of 3.25% Senior Notes For $1,000 Million 142
Jabil Circuit Completes Public Offering Of 7.75% Senior Notes For $312 Million 144
Baxter International Completes Public Offering Of Senior Notes Due 2017 For $500 Million 146
DuPont Completes Public Offering Of 2.75% Notes Due 2016 For $500 Million 148
DuPont Completes Public Offering Of 4.9% Senior Notes Due 2041 For $500 Million 150
Genzyme Completes Private Placement Of 5% Notes For $500 Million 152
Baxter International Completes Public Offering Of 4.25% Senior Unsecured Notes For $300 Million 153
DuPont Completes Public Offering Of 4.625% Senior Notes For $1,000 Million 154
Baxter International Completes Public Offering Of 4.5% Senior Notes For $500 Million 156
Eli Lilly Completes Public Offering Of 5.95% Notes For $400 Million 157
Bayer Completes Public Offering Of 4% Bonds For $284 Million 158
Bayer Completes Public Offering Of Floating Rate Bonds For $94.11 Million 160
Royal Philips Electronics Completes Public Offering Of 4.625% Senior Notes For $500 Million 161
The Cooper Companies Completes Private Placement Of $350 Million 163
Baxter International Completes Public Offering Of 5.9% Senior Notes For $600 Million 164
Fresenius Completes Private Placement Of $881.1 Million 165
Bayer Completes Public Offering Of 1.585% Bonds For $81.48 Million 166
PSS World Medical Completes Private Placement Of Senior Notes Due 2022 For $250 Million 167
DuPont Completes Public Offering Of 1.75% Notes Due 2014 For $400 Million 168
Bio-Rad Labs Completes Public Offering Of Senior Notes Due 2020 For $425 Million 170
Novartis Completes Public Offering Of 2.9% Senior Notes For $2,000 Million 171
Zimmer Holdings Completes Public Offering Of 5.75% Senior Unsecured Notes For $500 Million 173
Agilent Technologies Completes Public Offering Of 5.5% Senior Notes For $500 Million 175
Eli Lilly Completes Public Offering Of 4.2% Notes For $1,000 Million 177
Dupont Completes 5% Notes Offering For $750 Million 178
Bayer Completes Public Offering Of 1.955% Bonds For $122.23 Million 180
Eli Lilly Completes Public Offering Of 5.5% Notes For $696 Million 182
Royal DSM Completes Public Offering Of 5.25% Fixed Rate Notes For $966 Million 184
Fresenius Completes Private Placement Of $1209.54 Million 185
Agilent Technologies Completes Public Offering Of 5% Senior Notes For $500 Million 186
Novartis Completes Public Offering Of 4.4% Senior Notes For $1,000 Million 188
Zimmer Holdings Completes Public Offering Of 4.625% Senior Unsecured Notes For $500 Million 190
Agilent Technologies Completes Public Offering Of 4.45% Senior Notes For $250 Million 192
Eli Lilly Completes Public Offering Of 3.55% Notes For $1,000 Million 194
DuPont Completes Public Offering Of Notes Due 2014 For $600 Million 195
Dupont Completes 5% Notes Offering For $750 Million 197
SXC Health Solutions Prices Public Offering Of Common Stock For $471.1 Million 199
SSL International Completes Private Placement Of $123 Million 201
Medidata Solutions Completes IPO Of $101.43 Million 203
Ark Therapeutics Completes Private Placement Of $78 Million 205
Nanosphere Completes IPO Of $112.7 Million 207
Aeroflex Holding Completes IPO Of $267 Million 208
Tornier Completes Exercise Of Underwriters's Option For $179.95 Million 210
Kraton Performance Polymers Completes IPO For $139 Million 212
Cephalon Completes Public Offering Of $300 Million 214
Ark Therapeutics Completes Private Placement Of $12.20 Million 216
Alimera Sciences Completes IPO For $72 Million 218
WuXi PharmaTech Completes IPO Of $167.7 Million 220
Ark Therapeutics Completes Public Offering Of $36 Million 222
Emdeon Completes IPO Of $166.24 Million 224
MicroPort Scientific Completes Registered IPO Of $228.2 Million 226
EQT Partners Completes Acquisition Of HTL-Strefa 228
Technitrol Sells Medtech Component Business To Altor 230
Bridgepoint Acquires Rodenstock From Permira Funds 231
Bracco Group Sells Esaote To A Consortium Of Investors Led By Banca Intesa 233
EG Capital Group acquires Water Pik 235
Blackstone Capital Acquires Encore Medical 236
Warburg Pincus Acquires Bausch and Lomb 237
BC Partners And Silver Lake Acquire MultiPlan From The Carlyle Group And Welsh, Carson, Anderson and Stowe 240

List of Figures

Credit Suisse Group AG, Medical Equipment Deals Advised by Deal Type, 2006 to YTD 2012 1
Credit Suisse Group AG, Medical Equipment Deals Advised By Year, 2006 to YTD 2012 1
Credit Suisse Group AG, Medical Equipment Deals Advised By Region, 2006 to YTD 2012 1
Credit Suisse Group AG, Medical Equipment Deals Advised By Market, 2006 to YTD 2012 1
Credit Suisse Group AG, Medical Equipment Deals Advised By Year, 2006 to YTD 2012 10
Credit Suisse Group AG, Medical Equipment Deals Advised by Deal Type, 2006 to YTD 2012 11
Credit Suisse Group AG, Medical Equipment Deals Advised By Region, 2006 to YTD 2012 12
Credit Suisse Group AG, Medical Equipment Deals Advised by Market, 2006 to YTD 2012 13

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

Cynosure, Inc. (Symbol:CYNO) SWOT Analysis, Strategy, Revenues and Profits

Cynosure, Inc. (Symbol:CYNO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Mennen Medical Ltd. SWOT Analysis, Strategy, Revenues and Profits

Mennen Medical Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.